Skip to main content
Powered by ShareScore

Find research datasets worth reusing

Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.

221

datasets available to search

ShareScore release 0.9.0

Reset

Dataset results

221 results for “Montelukast”

Learn how ShareScore rates datasets ↗
ClinicalTrials.gov36/100

Pragmatic RCT of High-dose Oral Montelukast for Moderate and Severe Pediatric Acute Asthma Exacerbations

ClinicalTrials.gov study NCT03277170. IPD Sharing: YES. Countries: 1. Publications: 1.

controlledIPD-YESFeb 2026View details →
ClinicalTrials.gov36/100

The Addition of Montelukast to Fluticasone in the Treatment of Perennial Allergic Rhinitis

ClinicalTrials.gov study NCT00119015. IPD Sharing: Not stated. Countries: 1. Publications: 21.

restrictedIPD-UNDECIDEDFeb 2026View details →
ClinicalTrials.gov36/100

Phase 2 Study of Montelukast for the Treatment of Sickle Cell Anemia

ClinicalTrials.gov study NCT01960413. IPD Sharing: YES. Countries: 1. Publications: 1.

controlledIPD-YESFeb 2026View details →
ClinicalTrials.gov36/100

Effect of Montelukast on Experimentally-Induced RV16 Infection in Asthma

ClinicalTrials.gov study NCT00359073. IPD Sharing: NO. Countries: 1. Publications: 1.

closedIPD-NOFeb 2026View details →
ClinicalTrials.gov36/100

Montelukast to Treat Bronchiolitis Obliterans

ClinicalTrials.gov study NCT00656058. IPD Sharing: NO. Countries: 1. Publications: 1.

closedIPD-NOFeb 2026View details →
ClinicalTrials.gov36/100

Evaluation of Pharmacokinetic Interaction Between GSK3640254 and Caffeine, Metoprolol, Montelukast, Flurbiprofen, Omeprazole, Midazolam, Digoxin, and Pravastatin in Healthy Adults

ClinicalTrials.gov study NCT04425902. IPD Sharing: YES. Countries: 1. Publications: 1.

controlledIPD-YESFeb 2026View details →
ClinicalTrials.gov36/100

A Trial of Montelukast for Maintenance Therapy of Eosinophilic Esophagitis in Children

ClinicalTrials.gov study NCT01458418. IPD Sharing: Not stated. Countries: 1. Publications: 17.

restrictedIPD-UNDECIDEDFeb 2026View details →
ClinicalTrials.gov36/100

Montelukast and Inhaled Nasal Steroid Tx in Adult Obstructive Sleep Apnea (OSA)

ClinicalTrials.gov study NCT01089647. IPD Sharing: Not stated. Countries: 1. Publications: 1.

restrictedIPD-UNDECIDEDFeb 2026View details →
ClinicalTrials.gov36/100

The Effect of Montelukast on Asthma Control in Overweight/Obese Atopic Asthmatics

ClinicalTrials.gov study NCT01329939. IPD Sharing: UNDECIDED. Countries: 1. Publications: 1.

restrictedIPD-UNDECIDEDFeb 2026View details →
dryad32/100

Green quantitative spectrofluorimetric analysis of rupatadine and montelukast at nanogram scale using direct and synchronous techniques

<p>Two green sensitive spectrofluorimetric methods at nanogram scale were investigated for the determination of rupatadine fumarate (RUP) [method I] and its binary mixture with montelukast (MKT) [method II]. Method I is concerned with measuring the native fluorescence of RUP in presence of 0.10 M H2SO4 and 0.10 % w/v sodium dodecyl sulfate at 455 nm after excitation at 277 nm. The linearity range of the first method was 0.20-2.00 µg/mL with detection and quantitation limits of 11.00 ng/mL and 36.00 ng/mL, respectively. The second method includes the concurrent estimation of RUP and MKT in their co-formulated tablet preparation by applying first derivative synchronous spectrofluorimetric technique. The derivative intensities were measured for the two drugs in aqueous solution containing Mcllvaine's buffer pH 2.60 at fixed wavelength difference (Δλ) of 140 nm. Each drug was estimated at the zero contribution of the other. For RUP, the intensity was measured at 261 nm while MKT was quantitated at 371 nm. The method was linear over the range of 0.10-4.00 µg/mL and 0.20-1.60 µg/mL with limits of detection 4.00 and 5.00 ng/mL and limits of quantitation 13.38 and 15.00 ng/mL for RUP and MKT, respectively. The method was extended to determine the two analytes in laboratory-prepared mixtures and combined tablets. Validation of the two methods was performed according the official recommendations of the International Council of Harmonization (ICH). Statistical interpretation of data revealed that our results were in good agreement with the comparison method. Moreover, the greenness of the methods has been assessed and confirmed by applying three different reported assessment tools.</p>

opencc-zeroOct 2021View details →
ClinicalTrials.gov32/100

Study of Inhaled Corticosteroid Plus Montelukast Compared With Inhaled Corticosteroid Therapy Alone in Patients With Chronic Asthma (0476-386)

ClinicalTrials.gov study NCT00666679. IPD Sharing: NO. Countries: 0. Publications: 1.

closedIPD-NOFeb 2026View details →
ClinicalTrials.gov32/100

The Role of Montelukast in Rhinitis and Sleep

ClinicalTrials.gov study NCT00590772. IPD Sharing: Not stated. Countries: 0. Publications: 1.

restrictedIPD-UNDECIDEDFeb 2026View details →
ClinicalTrials.gov32/100

A Study Comparing Montelukast With Placebo in Children With Seasonal Allergic Rhinitis (0476-219)(COMPLETED)

ClinicalTrials.gov study NCT00968149. IPD Sharing: Not stated. Countries: 0. Publications: 1.

restrictedIPD-UNDECIDEDFeb 2026View details →
ClinicalTrials.gov32/100

Montelukast in Seasonal Allergic Rhinitis - Spring 2001 Study (0476-235)

ClinicalTrials.gov study NCT00972738. IPD Sharing: Not stated. Countries: 0. Publications: 1.

restrictedIPD-UNDECIDEDFeb 2026View details →
ClinicalTrials.gov32/100

Role of Montelukast in the Management of Chronic Rhinosinusitis With Nasal Polyps.

ClinicalTrials.gov study NCT05143502. IPD Sharing: Not stated. Countries: 1. Publications: 10.

restrictedIPD-UNDECIDEDFeb 2026View details →
ClinicalTrials.gov32/100

Effects of Mometasone Furoate Dry Powder Inhaler, Fluticasone Propionate, and Montelukast on Bone Mineral Density in Asthmatics (Study P03418)

ClinicalTrials.gov study NCT00394355. IPD Sharing: NO. Countries: 0. Publications: 1.

closedIPD-NOFeb 2026View details →
ClinicalTrials.gov32/100

Compare the Efficacy of Levocetirizine to Montelukast in Reducing Symptoms of SAR in Sensitive Subjects Exposed to Ragweed Pollen

ClinicalTrials.gov study NCT00315523. IPD Sharing: Not stated. Countries: 1. Publications: 1.

restrictedIPD-UNDECIDEDFeb 2026View details →
ClinicalTrials.gov32/100

Investigation the Safety and Efficacy of The Antileukotriene Agents, Montelukast, as Adjuvant Therapy in Obese Patients With Type 2 Diabetes Mellitus

ClinicalTrials.gov study NCT04075110. IPD Sharing: YES. Countries: 1. Publications: 1.

controlledIPD-YESFeb 2026View details →
ClinicalTrials.gov32/100

Montelukast in Bronchiolitis Obliterans Syndrome

ClinicalTrials.gov study NCT01211509. IPD Sharing: Not stated. Countries: 1. Publications: 2.

restrictedIPD-UNDECIDEDFeb 2026View details →
ClinicalTrials.gov32/100

The Clinical Effects of Montelukast in Patients With Perennial Allergic Rhinitis (0476-265)

ClinicalTrials.gov study NCT00092118. IPD Sharing: Not stated. Countries: 0. Publications: 1.

restrictedIPD-UNDECIDEDFeb 2026View details →

ScienceDex guides

Understand access before you commit

These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.

Compare curated datasets

Allen Brain Atlas

Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.

allen-brain-atlas
neuroscienceopenDocumentation, web resources, and API references are available online.
Last verified 2026-04-30Open record

Annotated Behaviour and Observability Dataset (ABODe)

ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.

abode-home-cage
behavioral-neuroscienceopenThe DataShare record exposes download links for annotations, documentation, license text, and the zipped per-snippet data directory.
Last verified 2026-04-30Open record

DANDI Archive for NWB datasets

DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.

dandi-nwb
electrophysiologyopenPublished Dandiset metadata and archive endpoints are available through the production DANDI API.
Last verified 2026-04-30Open record

International Brain Laboratory public data

The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.

ibl
behavioral-neuroscienceopenPublic sessions can be searched and loaded from the IBL public data server through ONE.
Last verified 2026-04-29Open record

OpenNeuro

OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.

openneuro
neuroscienceopenPublished datasets are available on demand over the internet.
Last verified 2026-04-29Open record